Skip to main content

Medivir

Medivir AB is a clinical-stage Swedish biopharmaceutical enterprise headquartered in Huddinge, Sweden. The company focuses on the development of innovative targeted therapies for the treatment of cancer indications, anchored by its proprietary clinical pipeline featuring drug candidates addressing primary liver cancer and oncology. Principal revenue is currently earned through research grants, pharmaceutical partnerships, and licensing milestone payments as drug candidates advance through clinical trials. Medivir AB is publicly listed on Nasdaq Stockholm.

5 of the funds FundTelligence covers report a position in Medivir.

Legal name
Medivir Ab
Sector
Health Care
Country
Sweden
Funds holding it
5

Funds holding Medivir

Loading...